The tyrosine kinase inhibitor dasatinib reduces the growth of intracellular <i>Mycobacterium tuberculosis</i> despite impairing T‐cell functionStephanie Wehrstedt, Steffen Stenger|European Journal of Immunology|2018Cited by 4